Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply
Are you familiar with the AETC Program HIV Care Tools App?
Image
south central logo

Description:

This presentation provides information on the current evidence supporting the use of long acting injectable cabotegravir (CAB-LA) for HIV prevention, indication, safety, efficacy, as well as advantages and disadvantages of long acting injectable cabotegravir (CAB-LA).